Asacol (mesalamine)

( DrugBank: Mesalamine / KEGG DRUG: Mesalamine )

1 disease

ID	Disease name (Link within this page)	Number of trials
97	Ulcerative colitis	4

97. Ulcerative colitis

Clinical trials : 2,630 / Drugs : 1,459 - (DrugBank : 265) / Drug target genes : 144 - Drug target pathways : 202

trials per page:

Showing 1 to 4 of 4 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00343850 (ClinicalTrials.gov)	September 2006	21/6/2006	Once Daily Versus Conventional Dosing of Asacol in the Maintenance of Quiescent Ulcerative Colitis	Once Daily Versus Conventional Dosing of Asacol in the Maintenance of Quiescent Ulcerative Colitis: ...	Ulcerative Colitis	Drug: Asacol (mesalamine)	University of Chicago	Procter and Gamble	Completed	18 Years	N/A	Both	30	Phase 3	United States
2	EUCTR2004-000611-25-IE (EUCTR)	19/10/2004	16/08/2004	A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, 52-Week Dose Comparison Study of the ...	A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, 52-Week Dose Comparison Study of the ...	Maintenance of remission of ulcerative colitis	Product Name: OPC-6535 Product Code: OPC-6535 Other descriptive name: 6-[2-(3,4-diethoxyphenyl)thiazol ...	Otsuka Maryland Research Institute, Inc.	NULL	Not Recruiting			Female: yes Male: yes	1725	Phase 3	Hungary;Ireland
3	EUCTR2004-000611-25-HU (EUCTR)	15/10/2004	21/07/2004	A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, 52-Week Dose Comparison Study of the ...	A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, 52-Week Dose Comparison Study of the ...	Maintenance of remission of ulcerative colitis	Product Name: OPC-6535 Product Code: OPC-6535 Other descriptive name: 6-[2-(3,4-diethoxyphenyl)thiazol ...	Otsuka Maryland Research Institute, Inc.	NULL	Not Recruiting			Female: yes Male: yes	1725	Phase 3	Hungary;Ireland
4	NCT00194818 (ClinicalTrials.gov)	June 2003	15/9/2005	Asacol Dosing Study for Active Ulcerative Colitis	Open Label Safety and Efficacy Trial of Twice Daily Dosing of Asacol vs. Three Times Per Day Dosing ...	Ulcerative Colitis	Drug: Asacol (mesalamine)	University of Washington	Procter and Gamble	Completed	18 Years	80 Years	Both	7	Phase 4	United States

First Previous1Next Last